QTTB logo

Q32 Bio (QTTB) Company Overview

Profile

Full Name:

Q32 Bio Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 28, 2018

Indexes:

Not included

Description:

QTTB, part of Q32 Bio, focuses on developing innovative therapies for autoimmune diseases. The company uses advanced technology to create treatments that target specific immune responses, aiming to improve patients' quality of life and reduce side effects compared to traditional therapies.

Key Details

Price

$2.16

Annual Revenue

-$6.65 M(-200.00% YoY)

Annual EPS

-$4.50(-25.54% YoY)

Beta

0.14

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 26, 2024

Analyst ratings

Recent major analysts updates

Feb 11, 25 Piper Sandler
Neutral
Feb 11, 25 BMO Capital
Market Perform
Dec 12, 24 Guggenheim
Neutral
Dec 12, 24 BMO Capital
Outperform
Dec 11, 24 Wells Fargo
Equal-Weight
Dec 11, 24 Raymond James
Outperform
Dec 11, 24 Piper Sandler
Overweight
Dec 11, 24 Oppenheimer
Outperform
Dec 11, 24 Leerink Partners
Market Perform
Dec 6, 24 BMO Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Q32 Bio?
  • Does Q32 Bio pay dividends?
  • What sector is Q32 Bio in?
  • What industry is Q32 Bio in?
  • What country is Q32 Bio based in?
  • When did Q32 Bio go public?
  • Is Q32 Bio in the S&P 500?
  • Is Q32 Bio in the NASDAQ 100?
  • Is Q32 Bio in the Dow Jones?
  • When was Q32 Bio's last earnings report?
  • When does Q32 Bio report earnings?
  • Should I buy Q32 Bio stock now?

What is the ticker symbol for Q32 Bio?

The ticker symbol for Q32 Bio is NASDAQ:QTTB

Does Q32 Bio pay dividends?

No, Q32 Bio does not pay dividends

What sector is Q32 Bio in?

Q32 Bio is in the Healthcare sector

What industry is Q32 Bio in?

Q32 Bio is in the Biotechnology industry

What country is Q32 Bio based in?

Q32 Bio is headquartered in United States

When did Q32 Bio go public?

Q32 Bio's initial public offering (IPO) was on March 28, 2018

Is Q32 Bio in the S&P 500?

No, Q32 Bio is not included in the S&P 500 index

Is Q32 Bio in the NASDAQ 100?

No, Q32 Bio is not included in the NASDAQ 100 index

Is Q32 Bio in the Dow Jones?

No, Q32 Bio is not included in the Dow Jones index

When was Q32 Bio's last earnings report?

Q32 Bio's most recent earnings report was on Feb 28, 2025

When does Q32 Bio report earnings?

The date for Q32 Bio's next earnings report has not been announced yet

Should I buy Q32 Bio stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions